11233

    530239

    SUVEN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SUVEN LIFE SCIENCES LTD Share Price Today

    SUVEN LIFE SCIENCES LTD is currently trading at ₹316, down by ₹1.0 from the previous close. The stock touched an intraday high of ₹320.05 and a low of ₹311.20 during the latest trading session. Over the past one year, SUVEN LIFE SCIENCES LTD has delivered a return of 10.13%, while the stock has gained 24.06% in the last one month.

    SUVEN LIFE SCIENCES LTD performance

    Today’s low Today’s high
    ₹ 311.20 ₹ 320.05
    ₹ 316.00
    52 week low 52 week high
    ₹ 124.11 ₹ 371.00
    ₹ 316.00
    Open Price ₹ 315.00
    Prev. Close ₹ 317.00
    Volume (Shares) 588295.00
    Total traded value ₹ 1859.01
    Upper Circuit ₹ 380.40
    Lower Circuit ₹ 253.60
    info

    Investment Returns

    Over 1 Month 24.06% Over 3 Months 56.39% Over 6 Months 149.32% Over 1 Year 10.13%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SUVEN LIFE SCIENCES LTD fundamentals


    • Market cap (Cr) 8,929.00
    • P/E Ratio (TTM) -163.07
    • Beta 1.17
    • Book Value / share 62.01
    • Return on equity -6.33%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -11.17
    info icon alternate text
    • Market cap (Cr) 8,938.90
    • P/E Ratio (TTM) -163.07
    • Beta 1.10
    • Book Value / share 62.01
    • Return on equity -6.33%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -11.17
    info icon alternate text

    SUVEN LIFE SCIENCES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.52
    Operating Expense 19.47
    Net Profit -11.17
    Net Profit Margin (%) -734.86
    Earnings Per Share (EPS) -0.50
    EBITDA -9.43
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 2.81
    Operating Expense 19.05
    Net Profit -13.47
    Net Profit Margin (%) -479.35
    Earnings Per Share (EPS) -0.60
    EBITDA -12.12
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.92
    Operating Expense 20.14
    Net Profit -15.45
    Net Profit Margin (%) -1679.34
    Earnings Per Share (EPS) -0.70
    EBITDA -14.12
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.87
    Operating Expense 17.23
    Net Profit -14.78
    Net Profit Margin (%) -790.37
    Earnings Per Share (EPS) -0.68
    EBITDA -13.41
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1.47
    Operating Expense 17.73
    Net Profit -15.07
    Net Profit Margin (%) -1025.17
    Earnings Per Share (EPS) -0.69
    EBITDA -13.72
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 7.11
    Operating Expense 75.89
    Net Profit -54.86
    Net Profit Margin (%) -771.58
    Earnings Per Share (EPS) -2.41
    EBITDA -49.09
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 6.66
    Operating Expense 64.46
    Net Profit -47.08
    Net Profit Margin (%) -706.90
    Earnings Per Share (EPS) -2.16
    EBITDA -41.21
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 11.69
    Operating Expense 49.29
    Net Profit -8.01
    Net Profit Margin (%) -68.52
    Earnings Per Share (EPS) -0.37
    EBITDA -2.34
    Effective Tax Rate (%) 11.09
    Particulars MAR 2023 (Values in Cr)
    Revenue 13.54
    Operating Expense 48.12
    Net Profit -20.13
    Net Profit Margin (%) -148.67
    Earnings Per Share (EPS) -1.13
    EBITDA -13.30
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 11.84
    Operating Expense 53.41
    Net Profit -36.25
    Net Profit Margin (%) -306.16
    Earnings Per Share (EPS) -2.69
    EBITDA -31.33
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 5.04
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -2323.57
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 12.38
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -951.97
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 17.21
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.01
    EBITDA Margin -822.08
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 6.61
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.04
    EBITDA Margin -987.58
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 5.58
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.04
    EBITDA Margin -535.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 36.66
    ROE % -6.33
    ROCE % -6.30
    Total Debt to Total Equity 0.00
    EBITDA Margin -692.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 38.77
    ROE % -2.36
    ROCE % -2.44
    Total Debt to Total Equity 0.00
    EBITDA Margin -122.16
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 39.14
    ROE % -4.20
    ROCE % -4.11
    Total Debt to Total Equity 0.00
    EBITDA Margin -154.87
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 32.74
    ROE % -9.17
    ROCE % -8.90
    Total Debt to Total Equity 0.01
    EBITDA Margin -297.38
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 28.66
    ROE % -5.73
    ROCE % -6.73
    Total Debt to Total Equity 0.01
    EBITDA Margin -168.40
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 37.72
    Total Assets 135.18
    Total Liabilities 135.18
    Total Equity 109.98
    Share Outstanding 21
    Price to Book Ratio 3.09
    Return on Assets (%) -118.90
    Return on Capital (%) -146.15
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 163.97
    Total Assets 284.90
    Total Liabilities 284.90
    Total Equity 270.04
    Share Outstanding 21
    Price to Book Ratio 2.57
    Return on Assets (%) -36.88
    Return on Capital (%) -38.91
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 184.28
    Total Assets 388.91
    Total Liabilities 388.91
    Total Equity 375.31
    Share Outstanding 21
    Price to Book Ratio 1.24
    Return on Assets (%) -30.41
    Return on Capital (%) -31.51
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 5.52
    Total Assets 108.03
    Total Liabilities 108.03
    Total Equity 96.14
    Share Outstanding 14
    Price to Book Ratio 2.83
    Return on Assets (%) -112.92
    Return on Capital (%) -126.25
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 46.64
    Total Assets 128.41
    Total Liabilities 128.41
    Total Equity 108.00
    Share Outstanding 12
    Price to Book Ratio 2.46
    Return on Assets (%) -56.18
    Return on Capital (%) -65.99
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 19.96
    Total Assets 808.89
    Total Liabilities 808.89
    Total Equity 799.51
    Share Outstanding 21
    Price to Book Ratio 3.09
    Return on Assets (%) -5.82
    Return on Capital (%) -5.89
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 153.44
    Total Assets 851.48
    Total Liabilities 851.48
    Total Equity 845.37
    Share Outstanding 21
    Price to Book Ratio 2.57
    Return on Assets (%) -0.94
    Return on Capital (%) -0.95
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 173.95
    Total Assets 860.44
    Total Liabilities 860.44
    Total Equity 853.44
    Share Outstanding 21
    Price to Book Ratio 1.24
    Return on Assets (%) -2.33
    Return on Capital (%) -2.36
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.14
    Total Assets 486.35
    Total Liabilities 486.35
    Total Equity 475.97
    Share Outstanding 14
    Price to Book Ratio 2.83
    Return on Assets (%) -7.45
    Return on Capital (%) -7.61
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 38.59
    Total Assets 415.38
    Total Liabilities 415.38
    Total Equity 401.65
    Share Outstanding 12
    Price to Book Ratio 2.46
    Return on Assets (%) -5.44
    Return on Capital (%) -5.62
    Particulars MAR 2025 (Values in Cr)
    Net Income -160.74
    Cash from Operations -154.70
    Cash from Investing 154.95
    Cash from Financing -0.75
    Net change in Cash 0.09
    Free Cash Flow -117.43
    Particulars MAR 2024 (Values in Cr)
    Net Income -106.07
    Cash from Operations -121.64
    Cash from Investing 94.43
    Cash from Financing -1.05
    Net change in Cash -22.08
    Free Cash Flow -121.64
    Particulars MAR 2023 (Values in Cr)
    Net Income -118.26
    Cash from Operations -114.87
    Cash from Investing -247.81
    Cash from Financing 395.53
    Net change in Cash 31.74
    Free Cash Flow -111.98
    Particulars MAR 2022 (Values in Cr)
    Net Income -121.99
    Cash from Operations -127.01
    Cash from Investing -22.22
    Cash from Financing 145.69
    Net change in Cash -4.07
    Free Cash Flow -107.24
    Particulars MAR 2021 (Values in Cr)
    Net Income -77.47
    Cash from Operations -94.87
    Cash from Investing 55.84
    Cash from Financing 34.85
    Net change in Cash -5.32
    Free Cash Flow -88.57
    Particulars MAR 2025 (Values in Cr)
    Net Income -47.07
    Cash from Operations -47.99
    Cash from Investing 44.21
    Cash from Financing -0.75
    Net change in Cash -3.93
    Free Cash Flow -10.71
    Particulars MAR 2024 (Values in Cr)
    Net Income -9.01
    Cash from Operations -26.73
    Cash from Investing -0.67
    Cash from Financing -1.05
    Net change in Cash -22.29
    Free Cash Flow -26.73
    Particulars MAR 2023 (Values in Cr)
    Net Income -20.12
    Cash from Operations -21.81
    Cash from Investing -348.82
    Cash from Financing 395.53
    Net change in Cash 23.79
    Free Cash Flow -18.92
    Particulars MAR 2022 (Values in Cr)
    Net Income -36.24
    Cash from Operations -36.10
    Cash from Investing -107.45
    Cash from Financing 145.69
    Net change in Cash 1.60
    Free Cash Flow -16.33
    Particulars MAR 2021 (Values in Cr)
    Net Income -27.95
    Cash from Operations -35.53
    Cash from Investing 2.41
    Cash from Financing 34.85
    Net change in Cash 0.58
    Free Cash Flow -29.23
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8804.30 64.71 13.36 126592.33 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.53 22.86 2.75 94.70 40.75 76.00
    SHREE PACETRONIX LTD. 128.05 15.28 2.69 48.01 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.04 0.00 2.74 23.03 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8804.30 84.32 12.70 126592.33 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.30 0.00 -9.07 27.86 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5848.30 26.17 4.84 6398.04 5010.00 6725.00

    SUVEN LIFE SCIENCES LTD shareholding pattern

    Holding
    31.31%
    65.47%
    0.47%
    2.73%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SUVEN LIFE SCIENCES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    316.00 -0.31 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 323.80
    • 26 Days 312.70
    • 10 Days 327.20
    • 50 Days 287.20
    • 12 Days 326.50
    • 100 Days 251.80
    • 20 Days 319.30
    • 200 Days 222.00
    319.95 PIVOT
    First Support 310.45 First Resistance 326.50 Second Support 303.90 Second Resistance 336.00 Third Support 294.40 Third Resistance 342.55
    RSI 51.76 ADX 42.09 MACD 13.81 Williams % R -88.00 Commodity Channel Index (CCI) -27.77
    Date 2026-07-24 Week 289268.00 Same Day 209677.00 Month 529667.00
    1 Year 1.18 3 Year 1.06
    Over 1 Month
    24.06% down
    Over 1 Year
    10.13% down
    Over 3 Months
    56.39% down
    Over 3 Years
    70.90% down
    Over 6 Months
    149.32% down
    Over 5 Years
    31.67% down

    SUVEN LIFE SCIENCES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Feb 2019 1.5 Interim 15 Feb 2019 Equity shares
    06 Feb 2018 1.5 Interim 07 Feb 2018 Equity shares
    08 Feb 2017 1.0 Interim 09 Feb 2017 Equity shares
    14 Mar 2016 1.0 Special 15 Mar 2016 Equity shares
    14 Mar 2016 1.0 Interim 15 Mar 2016 Equity shares
    23 Jul 2015 0.6 Final 25 Jul 2015 Equity shares
    24 Jul 2014 2.0 Special 26 Jul 2014 Equity shares
    24 Jul 2014 0.5 Final 26 Jul 2014 Equity shares
    01 Aug 2013 0.3 Final 05 Aug 2013 Equity shares
    17 Sep 2012 0.3 Final 19 Sep 2012 Equity shares
    01 Aug 2011 0.25 Final 03 Aug 2011 Equity shares
    19 Jul 2010 0.25 Final 21 Jul 2010 Equity shares
    14 Sep 2009 0.25 Final 16 Sep 2009 Equity shares
    11 Sep 2008 0.25 Final 13 Sep 2008 Equity shares
    21 Sep 2007 0.25 Final 25 Sep 2007 Equity shares
    25 Sep 2006 0.0 Final 27 Sep 2006 Equity shares
    05 Sep 2005 0.0 Final 08 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    02 Apr 2007 23 Mar 2007 1:1
    Ex-Date Old FV NEW FV Record Date
    23 Mar 2007 2.0 1.0 02 Apr 2007
    15 Jan 2004 10.0 2.0 23 Jan 2004
    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Feb 2019 1.5 Interim 15 Feb 2019 Equity shares
    06 Feb 2018 1.5 Interim 07 Feb 2018 Equity shares
    08 Feb 2017 1.0 Interim 09 Feb 2017 Equity shares
    14 Mar 2016 1.0 Special 15 Mar 2016 Equity shares
    14 Mar 2016 1.0 Interim 15 Mar 2016 Equity shares
    23 Jul 2015 0.6 Final 25 Jul 2015 Equity shares
    24 Jul 2014 2.0 Special 26 Jul 2014 Equity shares
    24 Jul 2014 0.5 Final 26 Jul 2014 Equity shares
    01 Aug 2013 0.3 Final 05 Aug 2013 Equity shares
    17 Sep 2012 0.3 Final 19 Sep 2012 Equity shares
    01 Aug 2011 0.25 Final 03 Aug 2011 Equity shares
    19 Jul 2010 0.25 Final 21 Jul 2010 Equity shares
    14 Sep 2009 0.25 Final 16 Sep 2009 Equity shares
    11 Sep 2008 0.25 Final 13 Sep 2008 Equity shares
    21 Sep 2007 0.25 Final 25 Sep 2007 Equity shares
    25 Sep 2006 0.0 Final 27 Sep 2006 Equity shares
    05 Sep 2005 0.0 Final 08 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    02 Apr 2007 23 Mar 2007 1:1
    Ex-Date Old FV NEW FV Record Date
    23 Mar 2007 2.0 1.0 02 Apr 2007
    15 Jan 2004 10.0 2.0 23 Jan 2004

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Suven Life Sciences Ltd?

    Answer Field

    Suven Life Sciences Ltd share price is for NSE ₹ 316.00 & for BSE ₹ 316.00 as on Jul 24 2026 03:30 PM.

    What is the Market Cap of Suven Life Sciences Ltd Share?

    Answer Field

    The market cap of Suven Life Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 24 2026 03:30 PM.

    What is the 52 Week High and Low of Suven Life Sciences Ltd?

    Answer Field

    The 52 Week High and Low of Suven Life Sciences Ltd for NSE is ₹ 371.00 and ₹ 124.11 and for BSE is ₹ 371.00 and ₹ 124.35.

    What is 1 year return for Suven Life Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 10.13%.

    What is the P/E Ratio of Suven Life Sciences Ltd Share?

    Answer Field

    As on Jul 24 2026 03:30 PM the price-to-earnings (PE) ratio for Suven Life Sciences Ltd share is -163.07.

    What is the PB ratio of Suven Life Sciences Ltd Share?

    Answer Field

    As on Jul 24 2026 03:30 PM, the price-to-book (PB) ratio for Suven Life Sciences Ltd share is 62.01.

    How to Buy Suven Life Sciences Ltd Share?

    Answer Field

    You can trade in Suven Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Suven Life Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Suven Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Suven Life Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |